News

Jigna Rao speaks on patient-centered approaches to TB care [and the effects of TB stigma]

The following is a transcript of a presentation made by Jigna Rao, who is a person who had TB and who still deals with its consequences, at the Cascades: Improving TB Care Symposium, organised by the Department of Global Health and Social Medicine at the Harvard Medical School, Médecins Sans Frontières, Partners In Health, the […]

Jigna Rao speaks on patient-centered approaches to TB care [and the effects of TB stigma] Read More »

European Approval of Delanamid, a new drug to fight TB: MSF & TAG’s responses

MSF Responds to EMA approval of new tuberculosis drug delamanid Background: On November 22, 2013, the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) recommended granting a conditional marketing authorisation for delamanid, only the second new TB drug to be developed in 50 years.  It is hoped that the new drug,

European Approval of Delanamid, a new drug to fight TB: MSF & TAG’s responses Read More »

Couldn’t get funding to go to ICASA, Cape Town, December 7-11

We tried to raise funding to attend ICASA, but could not find support to attend the meeting. Therefore, we won’t be reporting any news from this meeting. What follows if my original fundraising request. Background: I realise it is very very late in the game, but I would like to find support to cover the

Couldn’t get funding to go to ICASA, Cape Town, December 7-11 Read More »

New Anti-TB Strategy Target: Elimination of the Disease

A major shift in the global anti-tuberculosis (TB) strategy was announced at the Stop TB Symposium just prior to the 44th Union World Conference on Lung Health this month in Paris. Instead of setting modest targets for incremental improvements in TB control, which has been the norm for the past few decades, the TB community

New Anti-TB Strategy Target: Elimination of the Disease Read More »

Integrating methadone and TB-HIV treatment in sub-Saharan Africa

Preliminary results from the first programme to integrate directly observed therapy (DOT) TB treatment with methadone treatment for people who inject heroin in Africa show that it “is feasible and the patients found it quite acceptable despite stigma-related to TB/HIV treatments,” said Dr Robert Bruce of Yale University, speaking during the TB-HIV Late Breaker Session

Integrating methadone and TB-HIV treatment in sub-Saharan Africa Read More »

Xpert MTB/RIF highly sensitive and speeds time-to-initiation of TB treatment among PLHIV in Botswana

“The sensitivity of the [Xpert MTB/Rif TB test] was very high when used for intensified case finding under programmatic conditions in Botswana,” according to Dr. Tefera Agizew, TB-HIV researcher for the Botswana-USA Partnership (BOTUSA), speaking at the 44th Union World Conference on Lung Health held from October 31 to November 4th in Paris.[1] While South

Xpert MTB/RIF highly sensitive and speeds time-to-initiation of TB treatment among PLHIV in Botswana Read More »

44th Union World Conference on Lung Health: TB-HIV Highlights, Sunday — In Progress

The two key HIV-TB issues explored on Sunday involved Human Rights issues related to TB, and treatment and prevention of TB in pregnant women, children and adolescents living with HIV. Programme in Kenya reports very high rates of treatment completion of isoniazid preventive therapy (IPT) are possible in children living with HIV and plans to

44th Union World Conference on Lung Health: TB-HIV Highlights, Sunday — In Progress Read More »

44th Union World Conference on Lung Health: TB-HIV Highlights, Saturday — In Progress

Using mathematical modelling to optimise TB control in high-HIV prevalence settings The TB Modelling and Analysis Consortium (www.tb-mac.org), was launched in 2012 in order to coordinate modelling with TB research activities. A symposium on Saturday morning at the 44th Union World Conference on Lung Health was dedicated to explaining the value of modelling to help

44th Union World Conference on Lung Health: TB-HIV Highlights, Saturday — In Progress Read More »

44th Union World Conference on Lung Health: TB-HIV Highlights, Friday (in Progress)

CREATE’s Legacy Early Friday morning, a symposium reviewed the accomplishments of the Consortium to Respond Effectively to the AIDS/TB Epidemic (CREATE) — which was established to conduct research to explore ways to reduce TB in areas with a high burden of HIV.  The studies devised by CREATE enrolled over 1 million individuals, and contributed to

44th Union World Conference on Lung Health: TB-HIV Highlights, Friday (in Progress) Read More »

Meeting Highlights: More from the Stop TB Symposium on funding and the new Global TB Strategy

Dr Katherine Floyd, of WHO’s Global TB Programme, reviewed the findings of the Global Report and importantly, where the gaps are As noted in a previous post, the Global Report listed 5 priorities to accelerate and/or move beyond the 2015 TB targets: 1. Reach the ‘missed cases’ 2. Address MDR-TB as a public health crisis

Meeting Highlights: More from the Stop TB Symposium on funding and the new Global TB Strategy Read More »